Cervarix
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Cervical cancer is the neoplasm of the uterine cervix cells. Incidences of cervical cancer are increasing in the current scenario…
The bivalent human papillomavirus (HPV) vaccine, which generates immunity to the cancer-causing types 16 and 18 of the virus…
Currently there are only two available vaccines for primary prevention against human papillomavirus, Gardasil and Cervarix. Both…
The prevention of cervical cancer constitutes a main component of women’s health care. A necessary precondition for this…
With the licens u r e of GlaxoSmithKline’s human papillomavirus vaccine Cervarix in October, we will soon have two vaccines that…
Cervarix, a bivalent vaccine against HPV‐16 and ‐18, is licensed for the prevention of cervical cancer and has been chosen for…
TAY SUN KUIE, MBBS, MD, FRCOG, FAMS, Clinical Associate Professor & Senior Consultant, Department of Obstetrics & Gynaecology…
Every year in the UK over 2800 women develop invasive cervical cancer and almost 1100 die (Cancer Research UK, 2006). Until…